Anogenital cancers testing in Ortona
Find health labs to test for Anogenital cancers in Ortona and compare all offers by prices and services.
Tests that cover Anogenital cancers
HPV Test
Pap Smear by Laboratorio Lifebrain
Via Costantinopoli, 144 66026 Ortona (CH)
Pap Test by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
test HPV cavo orale autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
Pap Smear by Laboratorio Lifebrain
Viale Nettuno, 41 66023 Francavilla al Mare (CH)
7.1 km
Pap Smear by Laboratorio Lifebrain
Largo Gian Battista Vico, 15, Chieti 66100 Chieti (CH)
12.1 km
Pap Smear by Laboratorio Lifebrain
Via Ciancetta, 19 66020 San Giovanni Teatino (CH)
12 km
Pap Smear by Laboratorio Lifebrain
Via Vincenzo Bellini, 32 66100 Chieti Scalo (CH)
12.1 km
Pap Smear by Laboratorio Lifebrain
Via Roma, 108 64028 Silvi (TE)
20.3 km
Pap Smear by Laboratorio Lifebrain
Via Roma, 32 66034 Villa Santa Maria (CH)
28.1 km
Pap Smear by Laboratorio Lifebrain
Via Col Giuseppe Tirone, 8 67039 Sulmona (AQ)
32.5 km
Pap Smear by Laboratorio Lifebrain
Via Circonvallazione Occidentale, 91/B 67039 Sulmona (AQ)
32.5 km
Pap Smear by Laboratorio Lifebrain
Via Belgio 8/10 86039 Termoli (CB)
38.9 km
Pap Smear by Laboratorio Lifebrain
Via Paolo Borsellino, 3 38123 Trento (TN)
39.8 km
Anogenital cancers - symptoms and how to test
Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.
